Harbin Medical University - Tumor Hospital (The Third Affiliated Hospital)

Harbin, Heilongjiang

0 studies enrolling now · 1 studies all time

What they study most

Squamous Non Small Cell Lung Cancer

Studies at this site

• A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC — Status unconfirmed